Ibalizumab Long-Term Safety and Efficacy Data to be Presented at IDWeek 2017 in San Diego
MONTREAL, QUEBEC--(Marketwired - Sep 18, 2017) - Theratechnologies Inc. (Theratechnologies) (TSX:TH) today announced that the abstract entitled "48-Week Safety and Efficacy On-Treatment Analysis of Ibalizumab in Patients with Multi-Drug Resistant HIV- …